Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TARC and IgE levels before and after antiviral treatment in dermatitis patients
jRCT1031220349Recruiting
- Sponsor
- N/A
- Start
- Nov 2022
- Countries
- 1
01
Overview
Open-label, single-arm trial in dermatitis, sponsored by N/A. Primary endpoint: Primary endpoint (IgE). Started Nov 2022; status: recruiting.
02
Conditions
dermatitis
Beyond the preview
Go deeper on jRCT1031220349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031220349.